Illumina
-
Insight
Exclusive: Illumina, Grail deal faces EU antitrust veto – sources
By Foo Yun Chee BRUSSELS (Reuters) – Illumina’s acquisition of biotechnology firm Grail will doubtless be blocked by EU antitrust…
Read More » -
Insight
Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case
By Blake Brittain (Reuters) – A Delaware jury on Friday ordered Illumina Inc to pay greater than $333 million to…
Read More »